Table 2

Baseline demographic and clinical variables by medication adherence*

Variable≥80% adherence<80% adherenceTotalP value
Male, n (%)53 (96.36)21 (87.50)74 (93.67)0.16
White, n (%)24 (43.64)6 (25.00)30 (37.97)0.14
Visual field‡ baseline severity: uninterpretable, n (%)5 (9.80)4 (18.18)9 (12.33)0.69
Visual field baseline severity: severe, n (%)16 (31.37)5 (22.73)21 (28.77)
Visual field baseline severity: moderate, n (%)14 (27.45)5 (22.73)19 (26.03)
Visual field baseline severity: mild, n (%)16 (31.37)8 (36.36)24 (32.88)
Baseline visual acuity ≥20/50 in either eye, n (%)14 (25.45)6 (25.00)20 (25.32)1.0
Subject age, mean (SD)67.78 (8.79)63.96 (10.10)66.62 (9.31)0.11
Number of medications, mean (SD)2.37 (1.15)1.92 (1.14)2.23 (1.16)0.10
Number of days monitored, mean (SD)176.5 (44.37)212.7 (93.13)187.5 (64.81)0.33
REALM score§,mean (SD)60.98 (6.56)57.73 (13.68)60.03 (9.25)0.50
  • There was one subject missing medication data and four subjects missing REALM data.

  • *≥80% of prescribed doses taken according to electronic monitor; <80% of prescribed doses taken according to medication monitor.

  • †P value from χ2 for categorical variables and t-test for continuous variables.

  • ‡Visual fields with >33% fixation losses, false-positives or false-negatives and/or with artefact such as a cloverleaf pattern or rim defect were labelled uninterpretable.

  • §REALM, Rapid Estimate of Adult Literacy in Medicine, ranges 0–66, >60 is equivalent to ninth-grade reading level or above.